Get all your news in one place.
100's of premium titles.
One app.
Start reading
Fortune
Fortune
Ryan Hogg

Novo Nordisk gives foodmakers $900 million reason to worry

(Credit: Christopher Goodney—Bloomberg via Getty Images)

If food suppliers weren’t already spooked by the surge in demand for weight loss-aiding drugs like Wegovy and Ozempic, they’ve just been given a fresh $900 million reminder of why they should be. 

Danish drugmaker Novo Nordisk has the figures to prove growing interest in weight loss-aiding medication was far from just hype. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.